Monitor the Q1 2026 earnings release on May 7 for actual financial results and any pipeline updates. The Q4 2025 miss suggests continued cash burn; watch for cash runway and clinical trial progress commentary.
Price Chart
Executive Summary
Palvella Therapeutics announced it will report Q1 2026 financial results on May 7, 2026, with a conference call. The press release contains no Q4 2025 financial data; the synthetic earnings context shows a Q4 2025 EPS miss of -15.4% versus consensus. The filing is a routine earnings date announcement with no new material financial information.
Key Financial Metrics
Key Facts
- Q1 2026 financial results to be reported before market open on May 7, 2026
- Conference call scheduled for 8:30 a.m. ET on May 7, 2026
- No financial results or guidance provided in this press release
- Synthetic earnings context indicates Q4 2025 EPS of -$1.07 missed consensus of -$0.93 by -15.4%
Financial Impact
No financial data in this filing; Q4 2025 EPS miss of -15.4% per synthetic context
Risk Factors
- No FDA-approved products; clinical-stage biotech with no revenue
- Q4 2025 EPS miss of -15.4% indicates potential cost overruns or slower-than-expected progress
- Dependence on successful clinical trials and regulatory approvals for QTORIN platform
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3284733 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 4w ago | 144 | $155.47 $132.47 | ▼ −14.79% | ▼ −13.61% | $132.47 (−14.79%) |
Aug 9, 2026 7w ago | Institutional Cluster | $152.22 $157.00 | ▲ +3.14% | ▲ +4.05% | $132.47 (−12.97%) |
Aug 4, 2026 8w ago | 8-K | $151.99 $150.55 | ▼ −0.95% | ▲ +0.29% | $132.47 (−12.84%) |
Jul 30, 2026 9w ago | Press Release | $150.19 $150.33 | ▲ +0.09% | ▼ −3.87% | $132.47 (−11.80%) |
Jul 28, 2026 9w ago | Press Release | $142.84 $148.24 | ▲ +3.78% | ▲ +0.40% | $132.47 (−7.26%) |
Jun 30, 2026 13w ago | 8-K | $152.82 $141.77 | ▼ −7.23% | ▼ −6.20% | $132.47 (−13.32%) |
Jun 22, 2026 14w ago | Press Release | $118.84 $157.24 | ▲ +32.31% | ▲ +32.46% | $132.47 (+11.47%) |
Jun 16, 2026 15w ago | 8-K | $110.12 $149.68 | ▲ +35.92% | ▲ +35.72% | $132.47 (+20.30%) |
Jun 11, 2026 16w ago | Institutional Cluster | $106.38 $151.04 | ▲ +41.98% | ▲ +40.09% | $132.47 (+24.53%) |
May 15, 2026 20w ago | 8-K | $114.24 $116.51 | ▲ +1.99% | ▼ −0.13% | $132.47 (+15.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access